Wednesday, 4 November 2026

Aggregated from Times of India, NDTV, Hindustan Times, India Today and more · Every source linked and credited · Updated every 15 minutes

‘Habibi, call me Senator’: Abdul El-Sayed mocks Trump, Vance in victory speech Keralam CM Satheesan invokes Chanakya’s Arthashastra to explain tax strategy Those indulging in dharna, hunger strike in educational institutes liable to be ‘expelled’: HC Good news for Agniveers: Government extends tenure by two years ‘Dialling the wrong number’: Supreme Court rejects plea for rotation of SC/ST reserved seats ‘Will approach court if Police doesn’t take action:’ Delhi Advocate files complaint against Neha Bora over temple priests remarks Riyadh airport attack: 2nd Indian national succumbs to injuries, death toll reaches 14 Pramila Jayapal To Ro Khanna: How Indian-Origin Faces Performed In US Elections Centre Seeks Removal Of Delhi’s Qadeemi Mosque For Central Vista Project Land US Gets 1st Muslim Senator As Abdul El-Sayed Wins Michigan Senate Race

‘Habibi, call me Senator’: Abdul El-Sayed mocks Trump, Vance in victory speechKeralam CM Satheesan invokes Chanakya’s Arthashastra to explain tax strategyThose indulging in dharna, hunger strike in educational institutes liable to be ‘expelled’: HCGood news for Agniveers: Government extends tenure by two years‘Dialling the wrong number’: Supreme Court rejects plea for rotation of SC/ST reserved seats‘Will approach court if Police doesn’t take action:’ Delhi Advocate files complaint against Neha Bora over temple priests remarksRiyadh airport attack: 2nd Indian national succumbs to injuries, death toll reaches 14Pramila Jayapal To Ro Khanna: How Indian-Origin Faces Performed In US ElectionsCentre Seeks Removal Of Delhi’s Qadeemi Mosque For Central Vista Project LandUS Gets 1st Muslim Senator As Abdul El-Sayed Wins Michigan Senate Race

Business

Dr Lal PathLabs to acquire 70 pc stake in SN Genelab for Rs 168 crore

viaeconomictimes.indiatimes.com24 Sept

Dr Lal PathLabs Ltd is set to acquire a 70% stake in SN Genelab for around Rs 168 crore, expanding its capabilities in genomics and diagnostic services. This move includes a potent

Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to economictimes.indiatimes.com's own reporting rather than reproducing it — the excerpt above comes from economictimes.indiatimes.com's own feed.

Read the full story on economictimes.indiatimes.com ↗